Meningioma Study Points to CD73 as a Candidate Biomarker of Tumor Grade
An exploratory Brazilian study of 40 surgically resected meningiomas found that CD73 expression rises while PD-L1 falls in WHO grade ...
An exploratory Brazilian study of 40 surgically resected meningiomas found that CD73 expression rises while PD-L1 falls in WHO grade ...
A case report describes advanced ovarian cancer shrinking dramatically after the PD-1 inhibitor sintilimab was added to chemotherapy, enabling complete ...
A sweeping review reveals how the RNA modification N6-methyladenosine orchestrates lung cancer progression, drug resistance, immunotherapy response, and survival prediction.
A new case report describes a 70-year-old lung cancer patient with no cardiovascular risk factors who suffered a massive heart ...
A UC Davis clinical trial found that doxorubicin lymphodepletion before inhaled interleukin-15 therapy did not improve response rates in dogs ...
A sweeping review details how immune checkpoint inhibitors, combination regimens, CAR-T cells, vaccines, and oncolytic viruses are transforming treatment of ...
A phase II trial found that neoadjuvant camrelizumab plus apatinib, a chemotherapy-free combination of immunotherapy and anti-angiogenic therapy, produced manageable ...
Researchers have engineered biparatopic CAR-T cells that target both full-length MUC1 and the truncated MUC1β stub exposed after MUC1α shedding, ...
A pharmacovigilance analysis of US and Japanese adverse event databases finds that PD-1 and PD-L1 checkpoint inhibitors show a robust, ...
A new review details how enzymes that degrade the extracellular matrix and glycocalyx could open solid tumors to immune attack, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine